Home > Insider Trading > Filing (0001179110-12-017722)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1005201	Depomed Inc	DEPO	Pharmaceutical Preparations (2834)	943229046

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1367754	M Matthew Gosling	7999 Gateway Boulevard, Suite 300 Newark CA 94560	Senior Vp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-12-12	48,125	$3.09	65,702	No	4	M	Direct
Common Stock	Disposition	2012-12-12	65,702	$5.84	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2012-12-12	48,125	$0.00	48,125	$3.09

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,875		2020-01-17	No	4	M	Direct

Footnotes

70,000 stock options were granted on 1/17/2010 and exercisable in 48 equal monthly installments.
The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.7901 to $5.90. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.
The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2012.